These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 23197760)

  • 1. Concise review: cell therapy and tissue engineering for cardiovascular disease.
    Haraguchi Y; Shimizu T; Yamato M; Okano T
    Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
    Oikonomopoulos A; Kitani T; Wu JC
    Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
    Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing cell pluripotency for cardiovascular regenerative medicine.
    Chen H; Zhang A; Wu JC
    Nat Biomed Eng; 2018 Jun; 2(6):392-398. PubMed ID: 31011193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells.
    Kim YJ; Tamadon A; Kim YY; Kang BC; Ku SY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
    Ben M'Barek K; Habeler W; Monville C
    Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology.
    Buikema JW; Van Der Meer P; Sluijter JP; Domian IJ
    Stem Cells; 2013 Dec; 31(12):2587-98. PubMed ID: 23843322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Functional Cardiac Tissues for Regenerative Medicine Applications.
    Tomov ML; Gil CJ; Cetnar A; Theus AS; Lima BJ; Nish JE; Bauser-Heaton HD; Serpooshan V
    Curr Cardiol Rep; 2019 Aug; 21(9):105. PubMed ID: 31367922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies.
    Templin C; Kränkel N; Lüscher TF; Landmesser U
    Curr Pharm Des; 2011 Oct; 17(30):3280-94. PubMed ID: 21919874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in identifying the best source of stem cells for cardiac regeneration therapy.
    Dixit P; Katare R
    Stem Cell Res Ther; 2015 Mar; 6(1):26. PubMed ID: 25886612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy for myocardial regeneration.
    Liu J; Sluijter JP; Goumans MJ; Smits AM; van der Spoel T; Nathoe H; Doevendans PA
    Curr Mol Med; 2009 Apr; 9(3):287-98. PubMed ID: 19355911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
    Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
    Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Engineer a Human Cardiac Patch for Therapy?
    Zhang J; Zhu W; Radisic M; Vunjak-Novakovic G
    Circ Res; 2018 Jul; 123(2):244-265. PubMed ID: 29976691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Bio-Engineering: Current State of the Art.
    Simon-Yarza T; Bataille I; Letourneur D
    J Cardiovasc Transl Res; 2017 Apr; 10(2):180-193. PubMed ID: 28265882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
    Tohyama S; Fukuda K
    Circ Res; 2017 May; 120(10):1558-1560. PubMed ID: 28495993
    [No Abstract]   [Full Text] [Related]  

  • 20. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.